The human chromatin remodeling complex p400 restricts HIV-1 transcription in a Tat-dependent manner
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf1323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Chuan Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, Unite…. Hauptthemen laut MEDLINE: HIV-1, tat Gene Products, Human Immunodeficiency Virus, Chromatin Assembly and Disassembly, Transcription, Genetic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, NIAID.
Abstract (Originalsprache)
The chromatin landscape surrounding integrated HIV proviruses critically shapes viral transcription. We systematically examined ATP-dependent chromatin remodeling complexes (SWI/SNF, ISWI, CHD, and INO80) as regulators of HIV expression and identified the p400 complex, a member of the INO80 family, as a potent repressor. Depleting p400 subunits, including the EP400 ATPase and DMAP1, markedly increased HIV transcription and RNAPII elongation at the proviral locus. Mechanistically, EP400 associates with the RNAPII C-terminal domain, while DMAP1 directly engages the viral transactivator Tat, with repression requiring simultaneous interactions among EP400, DMAP1, and Tat. Loss of either EP400 or DMAP1 selectively increased infection and transcription of Tat-competent, but not Tat-deficient, viruses. Although p400 is recruited to active HIV chromatin via RNAPII in a Tat-independent manner, it restrains elongation once Tat accumulates during reactivation. DMAP1 binding to Tat’s basic domain blocks Tat-TAR RNA interaction, thereby limiting p-TEFb-mediated RNAPII Ser2 phosphorylation and elongation. Thus, the p400 complex functions as a host restriction factor that limits Tat-dependent HIV transcription via a Tat-dependent proximal mechanism, highlighting the p400-Tat interface as a potential target for HIV cure strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
- The Skaggs Graduate School of Chemical and Biological Sciences, The Scripps Research Institute, Jupiter, FL 33458, United States.
ORCID-Profile: Susana T Valente
Förderung
- NIH HHS
- NIAID NIH HHS
- NIAID
- NIH
Zitieren
APA
Li, C., Ma, Y., Mori, L. P., Yang, H., Wang, Y., Venables, T. T., Bronson, R., Milione, R. R., Pipkin, M. E., & Valente, S. T. (2025). The human chromatin remodeling complex p400 restricts HIV-1 transcription in a Tat-dependent manner. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf1323
Vancouver
Li C, Ma Y, Mori LP, Yang H, Wang Y, Venables TT, et al. The human chromatin remodeling complex p400 restricts HIV-1 transcription in a Tat-dependent manner. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf1323
BibTeX
@article{Li2025,
author = {Li, Chuan and Ma, Yuan and Mori, Luisa P and Yang, Huiming and Wang, Yi and Venables, Thomas T and Bronson, Ronald and Milione, Ryan R and Pipkin, Mathew E and Valente, Susana T},
title = {The human chromatin remodeling complex p400 restricts HIV-1 transcription in a Tat-dependent manner},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf1323}
}
EUVIMED